Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients

SOS Oxygene Mediterranee120 enrolled

Overview

Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Chronic Respiratory Disease Hypoxemia

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * chronic respiratory disease patients with chronic hypoxemia * First prescribed long term oxygenotherapy Exclusion Criteria: * patients with NIV and CPAP * vital pronostic \< 3 months

Locations (1)

CHU Arnaud de Villeneuve

Montpellier, France

Outcomes

Primary Outcomes

oxygen use

time of oxygen use

Time frame: 6 month

Secondary Outcomes

respiratory disease severity based on GOLD standards

Time frame: baseline

quality of life assessed by a questionnaire (VQ-11)

Time frame: baseline, 3 month and 6 month

precarity score assessed by a questionnaire (EPICE)

Time frame: baseline